Quironsalud Madrid
Hematology oncology in Spain typically costs from $43,400 to $276,500. Final expenses depend on the specific diagnosis, the complexity of the treatment protocol, and the duration of hospital stay. Patients can expect 30-80% savings compared to the prices in the US.
Typical Hematology Oncology Costs in Spain
Major medical centers for hematology are located in Madrid, Barcelona, and Pamplona. Costs may vary between cities based on the facility type and specialist expertise. Consult with a specialist to get accurate pricing for your specific case and medical history.
| Turcja | Austria | Hiszpania | |
| Terapia komórkami CAR-T | od $150,000 | od $350,000 | od $330,000 |
| Terapia biologiczna | od $5,500 | od $20,000 | od $15,000 |
| Przeszczepienie szpiku kostnego allogeniczne od dawcy spokrewnionego | od $65,000 | od $150,000 | od $13,725 |
| Przeszczep szpiku kostnego | od $36,000 | od $140,000 | od $71,782 |
| Plazmafereza | od $1,200 | od $2,000 | od $1,800 |
Państwo nie płacą za usługi Bookimed. Ceny leczenia onkohematologii na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu onkohematologii. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Przy przechodzeniu procedur w onkohematologii zawsze można liczyć na nasze wsparcie.
Dr Luis Madero posiada ponad 37-letnie doświadczenie w hematologii i onkologii dziecięcej, specjalizując się w złożonych schorzeniach krwi oraz przeszczepach szpiku kostnego w Quironsalud Madryt.
Dr Graupera kieruje Oddziałem Hematologii i Onkologii w Sant Joan De Déu – jednym z najlepszych szpitali dziecięcych w Europie, prowadzącym przełomowe badania nad nowotworami dziecięcymi.
Specjalista w dziedzinie pediatrycznego przeszczepiania szpiku kostnego – dr Rives Sola zajmuje się młodymi pacjentami w szpitalu dziecięcym SJD Barcelona.
Przeprowadzono ponad 1 100 zabiegów hematologicznych – dr Cobo Valien specjalizuje się w leczeniu chłoniaków i białaczek w Centro Médico Teknon.
Konsultacja w sprawie nowotworu hematologicznego w Hiszpanii wymaga potwierdzenia precyzyjnego podtypu, mutacji genetycznych i wskaźników stadiów. Poproś o kopię swojego raportu patologicznego, w tym wyniki cytogenetyki i FISH. Te markery określają, czy niezbędne są zaawansowane protokoły, takie jak terapia CAR T-cell lub specyficzne przeszczepy szpiku kostnego.
Wgląd Ekspertów Bookimed: Ośrodki o dużej liczbie pacjentów w Hiszpanii, takie jak Klinika Uniwersytetu Nawarry czy Centro Médico Teknon, często zapewniają szybszy dostęp do specjalistycznej diagnostyki, takiej jak PET-CT i profilowanie molekularne. Dla dzieci, Szpital Dziecięcy SJD w Barcelonie jest światowym liderem, wykonującym 14 000 operacji rocznie. Wybór placówki z zintegrowanymi jednostkami badawczymi może skrócić czas od diagnozy do zaawansowanych zabiegów, takich jak haploidentyczny przeszczep komórek macierzystych.
Konsensus Pacjentów: Pacjenci podkreślają potrzebę pełnego profilowania genetycznego od samego początku, ponieważ te szczegóły często wpływają na kwalifikację do leczenia. Wielu poleca przyprowadzenie osoby, która będzie robić notatki, ponieważ techniczne szczegóły dotyczące stadiów i markerów mutacyjnych mogą być przytłaczające podczas pierwszej wizyty.
Verify a Spanish hematology-oncology clinic by checking for Joint Commission International (JCI) accreditation and European Society for Medical Oncology (ESMO) designation. Spain hosts numerous ASCO-certified facilities. Top centers like Clinica Universidad de Navarra and Centro Médico Teknon maintain these rigorous global safety and quality benchmarks.
Bookimed Expert Insight: Our data shows that top-rated Spanish clinics like Centro Médico Teknon, which serves 10,000+ patients annually, often hold multiple redundant accreditations. They combine JCI safety standards with European Foundation for Quality Management (EFQM) awards. This dual-layer certification typically correlates with higher patient trust levels and smoother international service coordination.
Patient Consensus: Patients note that while private clinics offer faster access to PET-CT scans, it is essential to cross-reference doctor credentials with official registries. Many emphasize that international translators make navigating these accredited facilities significantly easier during complex treatments.
A hematology oncology treatment plan in Spain should detail your specific protocol and success metrics. Ask if the goal is curative or palliative. Inquire about advanced options like CAR T-cell therapy or bone marrow transplantation. Confirm how many cycles are planned before your first progress assessment.
Bookimed Expert Insight: Spanish centers like Quironsalud Madrid and Clinica Universidad de Navarra often provide access to international clinical trials. Ask your oncologist if a trial is a viable first-line option. These trials sometimes offer cutting-edge therapies before they become the global standard, which can be a decisive factor in complex hematological cases.
Patient Consensus: Patients emphasize asking about egg or sperm banking early to avoid future regrets. They also note that having a dedicated translator at clinics like Centro Médico Teknon makes clarifying complex medical steps much easier.
Madrid and Barcelona are Spain's primary hubs for advanced hematology-oncology. These cities host centers offering CAR T-cell therapy and bone marrow transplants. Facilities like Quironsalud Madrid and Centro Médico Teknon hold JCI accreditation. They provide specialized care for complex blood cancers and lymphomas.
Bookimed Expert Insight: Data shows a clear specialization gap between major cities. While Madrid centers like Quironsalud Madrid focus on high-volume clinical trials for neurodegenerative and cancer research, Barcelona's SJD Barcelona Children's Hospital dominates pediatric cases. SJD serves 450,000 patients annually and houses a dedicated Molecular Medicine Laboratory specifically for childhood tumors. Patients seeking the fastest start should note that private facilities in these hubs begin treatment within 1–2 weeks, compared to longer wait times in public university hospitals.
Patient Consensus: Patients note that traveling to Madrid or Barcelona is essential for complex initial diagnoses. They find the presence of professional translators makes navigating these advanced medical systems much easier and more comfortable.
Spain manages specialised haematology oncology for international patients through a private hospital network. This system provides rapid access to CAR T-cell therapy, allogeneic bone marrow transplants, and genomic profiling. Accredited centres in Barcelona and Madrid integrate research and clinical care to treat complex blood cancers.
Bookimed Expert Insight: Spain's strength lies in its high-volume bone marrow transplant units. Data shows that centres performing over 40,000 procedures annually, such as Hospital Quiron Barcelona, host units like the Baselga Institute of Oncology. These units provide access to phase 1 clinical trials. These trials are frequently unavailable in standard hospital settings elsewhere.
Patient Consensus: Patients in Spain trust the medical staff. They also appreciate the smooth experience provided by on-site translators. Many find the clinical environments exceptionally clean and professional during their treatment.
Spanish hospitals offer haematological care through bone marrow transplants and pioneering CAR T-cell therapies. Facilities like Clínica Universidad de Navarra and SJD Barcelona Children’s Hospital provide targeted therapies. They also offer haploidentical transplants and hospital-manufactured cellular treatments. These centres integrate molecular profiling and clinical trials for leukaemia, lymphoma, and myeloma.
Bookimed Expert Insight: Spain has a unique academic CAR-T model. Reference hospitals there manufacture their own cellular therapies. This allows experts like Dr Francesc Bosch to offer treatments at lower costs. Clinics such as Sant Joan de Déu also specialise in paediatric CAR-T for acute lymphoblastic leukaemia.
Patient Consensus: Patients find the experience in Spain smooth due to professional staff and helpful translators. They report high levels of trust in doctors. They also appreciate the cleanliness and comfort of the facilities during long treatment phases.
International patients access Spanish oncology trials through major research hubs in Barcelona and Madrid. Spain participates in 33% of clinical trials launched in the European Union. Specialised units offer immuno-oncology, CAR T-cell therapy, and molecular research for complex cases.
Bookimed Expert Insight: Spanish research hospitals frequently use multidisciplinary tumour boards. These boards match patients with trials across their entire network. For example, Dr Manuel Sureda González at Quironsalud Torrevieja integrates personalised RNA microarrays and pharmacogenomics. This system allows doctors to pivot patients to alternative experimental therapies if needed.
Patient Consensus: Patients find the experience smooth when using translators to navigate medical consent forms. Trust in Spanish specialists is high. This is especially true when doctors provide clear medication plans for follow-up care.
In Spain, treatment for haematological cancers typically begins within 14 to 28 days in private hospitals. Public system timelines usually range from 33 to 35 days. Acute leukaemias or aggressive lymphomas are triaged as urgent. This often allows therapy to start within days at specialised centres.
Bookimed Expert Insight: Clinics with high international volumes, like Centro Médico Teknon, often provide same-day results for basic diagnostics. This efficiency can shorten the wait for a final treatment plan. Clinics like Quironsalud Madrid offer clinical trials. These may provide newer therapies but require longer screening to confirm eligibility.
Patient Consensus: Patients report that working with translators makes coordinating urgent consultations much easier. They note that private care in Spain provides high cleanliness. Medical staff also clearly explain medication requirements for the upcoming treatment phase.
Language barriers do not hinder haematology oncology care in Spain at private international clinics. JCI-accredited centres in Barcelona and Madrid provide bilingual medical coordinators and multilingual support. These specialists manage complex consultations for leukaemia, lymphoma, and bone marrow transplants for clinical safety.
Bookimed Expert Insight: Clinics with many international patients, like Hospital Ruber Internacional, often have staff trained in the USA or UK. Dr Jaume Mora Graupera at SJD Barcelona, for example, completed fellowships at Memorial Sloan Kettering. This training background means doctors naturally align with Australian clinical communication styles and English medical terminology.
Patient Consensus: Patients in Spain find that dedicated translators make the hospital experience smooth and easy. They report that doctors take extra time to make medication instructions for the next phase perfectly clear.